Ex Parte RingotDownload PDFPatent Trials and Appeals BoardJun 27, 201914115840 - (D) (P.T.A.B. Jun. 27, 2019) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE FIRST NAMED INVENTOR 14/115,840 02/03/2014 Claude Ringot 35161 7590 07/01/2019 DICKINSON WRIGHT PLLC 1825 Eye St., NW Suite 900 WASHINGTON, DC 20006 UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 338180-01002 5802 EXAMINER KOLLIAS, ALEXANDER C ART UNIT PAPER NUMBER 1767 NOTIFICATION DATE DELIVERY MODE 07/01/2019 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): dwpatents@dickinsonwright.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte CLAUDE RINGOT Appeal2017-007007 Application 14/115,840 Technology Center 1700 Before RAEL YNN P. GUEST, A VEL YN M. ROSS, and JEFFREY R. SNAY, Administrative Patent Judges. SNAY, Administrative Patent Judge. DECISION ON APPEAL 1 Appellants2 appeal under 35 U.S.C. § 134(a) from the Examiner's decision rejecting claims 1-5 and 14--19. We have jurisdiction under 35 U.S.C. § 6(b). We affirm. 1 We cite to the Substitute Specification ("Spec.") filed November 5, 2013; Final Office Action ("Final Act.") dated September 15, 2016; Appellants' Appeal Brief ("App. Br.") filed December 14, 2016; Examiner's Answer ("Ans.") dated February 15, 2017, and Appellants' Reply Brief ("Reply Br.") filed March 29, 2017. 2 Appellants are the Applicants, COMP AGNIE GENERALE DES ETABLISSEMENTS MICHELIN and MICHELIN RECHERCHE ET TECHNIQUE S.A., which are identified in the Appeal Brief as the real parties in interest (App. Br. 1 ). Appeal2017-007007 Application 14/115,840 REJECTI0NS 3 I. Claims 1--4 and 19 stand rejected under 35 U.S.C. § I03(a) as unpatentable over Vasseur. 4 II. Claims 1-5 and 14--18 stand rejected under 35 U.S.C. § I03(a) as unpatentable over Lopitaux. 5 BACKGROUND The subject matter on appeal relates to rubber compositions suited for use in manufacture of tire treads. Spec. 1. Claim I-the sole independent claim on appeal-reads: 1. A tire, a tread of the tire comprising a rubber composition compnsmg: from 3 5 to 65 phr of an emulsion styrene/butadiene copolymer (E-SBR), wherein a content of trans-1,4-butadienyl units is greater than 50% by weight, based on the total of the butadienyl units in the E-SBR; from 35 to 65 phr of a polybutadiene (BR); optionally, from O to 30 phr of another diene elastomer, wherein the diene elastomer is selected from the group consisting of natural rubber (NR), synthetic polyisoprenes (IRs), solution butadiene/styrene copolymers (SBRs), butadiene/isoprene copolymers (BIRs ), isoprene/styrene copolymers (SIRs ), and combinations thereof; from 90 to 150 phr of a reinforcing inorganic filler, wherein the reinforcing inorganic filler is silica; a plasticizing system comprising: 3 The Examiner incorporates and maintains the rejections set forth in a prior Non-Final Office action ("Non-Final Act.") dated May 23, 2016. Final Act. 2-3. 4 US 2004/0127617 Al, published July 1, 2004. 5 WO 2010/105984 Al, published September 23, 2010. Appellants do not dispute the Examiner's reliance on US 2012/0065292 Al, published March 15, 2012, as an English language version of Lopitaux. 2 Appeal2017-007007 Application 14/115,840 a hydrocarbon resin (A) exhibiting a Tg greater than 20°C in an amount between 10 and 60 phr, wherein the hydrocarbon resin (A) is selected from the group consisting of cyclopentadiene homopolymer or copolymer resins, dicyclopentadiene homopolymer or copolymer resins, terpene homopolymer or copolymer resins, Cs fraction homopolymer or copolymer resins, C9 fraction homopolymer or copolymer resins, a-methylstyrene homopolymer or copolymer resins, and combinations thereof; and a plasticizer (B) which is liquid at 20°C and exhibits a Tg of less than -20°C in an amount between 10 and 60 phr selected from the group consisting of liquid diene polymers, polyolefin oils, naphthenic oils, paraffinic oils, DAE oils, MES oils, TDAE oils, RAE oils, TRAE oils, SRAE oils, mineral oils, ether plasticizers, ester plasticizers, phosphate plasticizers, sulphonate plasticizers, and combinations thereof; wherein the total amount of plasticizers, A+B, is between 50 and 100 phr. Appeal Br. Exh. A (Claims Appendix). OPINION Rejection I With regard to Rejection I, Appellants argue the claims as a group. See App. Br. 4--11. In accordance with 37 C.F.R. § 4I.37(c)(l)(iv), we select claim 1 as representative. Claims 2--4 and 19 stand or fall with representative claim 1. Relevant to Appellants' arguments on appeal, the Examiner finds that Vasseur discloses a tire tread rubber composition having all of the recited components within concentrations ranges that overlap the ranges recited in claim 1. See Non-Final Act. 4--5. The Examiner also finds that Vasseur discloses the same liquid plasticizer as is described in the Specification as exhibiting a glass transition temperature within the recited range. Id. at 5. 3 Appeal2017-007007 Application 14/115,840 Appellants argue that Vasseur does not recognize concentration of the recited components as "result-effective operating parameter[ s] which could contribute to the improved wet grip and wear resistance while maintaining desirable rolling resistance." App. Br. 5. However, we do not read the Examiner's rejection as involving optimization of component concentration. Rather, the Examiner finds, and Appellants do not dispute, that Vasseur discloses compositions formulated from the same components in concentration ranges that overlap the recited concentration ranges. Thus, the Examiner's obviousness determination is premised on Vasseur' s teaching of a specific range of component concentrations that include, inter alia, obvious concentrations within the recited ranges. When claimed ranges overlap or lie inside ranges disclosed by the prior art for every component in a claim, a prima facie case of obviousness is established. See In re Peterson, 315 F .3d 1325, 1329 (Fed. Cir. 2003); In re Geisler, 116 F.3d 1465, 1469-70 (Fed. Cir. 1997). Indeed, the law is replete with cases in which the difference between the claimed invention and the prior art is some range or other variable within the claims. These cases have consistently held that the Appellants must show that the particular range is critical, generally by showing that the claimed range achieves unexpected results relative to the prior art range. In re Woodruff, 919 F.2d 1575, 1578 (Fed. Cir. 1990). In the instance case, Appellants have not made this showing. Appellants also argue that the Examiner does not present evidence to support the finding that Vasseur discloses a plasticizer having a glass transition temperature less than -20°C. App. Br. 5. In response, the Examiner points to Vasseur' s teaching of glycerol fatty acid triesters derived from fatty acids comprising oleic acid (Ans. 8) (citing Vasseur ,r 67), and the 4 Appeal2017-007007 Application 14/115,840 identification in the Specification of such glycerol triesters comprising oleic acid as meeting the recited glass transition temperature (id. at 7) ( citing Spec. 11 ). Appellants do not challenge the Examiner's evidence in the Reply Brief. On this record, we are not persuaded of error in the Examiner's finding that Vasseur teaches use of a plasticizer meeting the recited glass transition characteristic. Appellants argue that Vasseur does not teach a specific total plasticizer concentration of 50-100 phr and a specific E-SBR concentration of 35---65 phr, as recited in claim 1. App. Br. 6-7. These arguments do not address the Examiner's finding that Vasseur discloses overlapping concentration ranges for these components. Appellants further argue that Vasseur does not teach a silica concentration within the recited range of 90- 150 phr. Id. at 6-7. The Examiner points to Vasseur's teachings at paragraph 95 and claim 22 identifying use of silica at a concentration greater than 70 phr, a range which encompasses and thus prima facie renders obvious the claimed range. Ans. 13. Appellants do not challenge the Examiner's evidence in the Reply Brief. Finally, Appellants contend that evidence in the Specification and Declaration demonstrate unexpected results achieved by the recited composition. App. Br. 8-10. A showing of unexpected results generally must be commensurate in scope with a claimed range. In re Harris, 409 F.3d 1339, 1344 (Fed. Cir. 2005). Appellants rely on measurements reported in the Specification for a single inventive sample (C.3). App. Br. 9. The Declaration points to the same sample described in the Specification. In contrast, claim 1 encompasses numerous compositions characterized by different component concentrations over substantially varied ranges. 5 Appeal2017-007007 Application 14/115,840 Appellants have not demonstrated how that single composition serves as persuasive evidence of an unexpected result over a range of formulations that is commensurate with the claim. For the foregoing reasons, Appellants' arguments do not persuade us of reversible error. Rejection I is sustained. Rejection II With regard to Rejection II, Appellants again argue the claims as a group. See App. Br. 11-17. We again select claim 1 as representative. The Examiner finds that Lopitaux, like Vasseur, discloses a tire tread rubber composition having all of the recited components within concentrations ranges that overlap the ranges recited in claim 1. See Non- Final Act. 7-9. Appellants present essentially the same arguments as are presented regarding the rejection over Vasseur-namely, that Lopitaux does not teach the specifically recited component concentration ranges and does not recognize such concentrations as result-effective variables. App. Br. 11-13. These arguments are not persuasive for the same reasons give above in connection with Rejection I. Appellants also argue that Lopitaux does not suggest use of silica at a concentration greater than 90 phr. Id. at 13-14. However, as Appellants acknowledge (id. at 13), Lopitaux teaches silica at 20-200 phr, preferably 30-150 phr, both of which include concentrations greater than 90 phr. Appellants argue that Lopitaux does not specify the content of trans- 1, 4-butadienyl units in the disclosed E-SBR. Id. at 14. The Examiner finds the recited 1,4-butadienyl content is met or suggested by Lopitaux's teaching 6 Appeal2017-007007 Application 14/115,840 ofE-SBR having a content oftrans-1,4-bonds of 15-75%. Ans. 40 (citing Lopitaux ,r 25). Appellants neither challenge nor address the Examiner's cited evidence in the Reply Brief. Appellants' contention of unexpected results (App. Br. 16-17) is not persuasive for the reasons set forth above in connection with Rejection I. For the foregoing reasons, Appellants' arguments do not persuade us of reversible error. Rejection II also is sustained. DECISION The Examiner's decision rejecting claims 1-5 and 14--19 is affirmed. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED 7 Copy with citationCopy as parenthetical citation